Please join Insamo CEO Tim Craven in a conversation about "Undruggable Targets and the Advent of Generative AI" at?SynBioBeta?2024, happening on?May 7th?from 2:45 to 3:30 pm. We're diving deep into how generative AI is revolutionizing the hunt for new small molecule targets, especially those in previously inaccessible areas of biology. This session promises to be a fascinating exploration of the interface between advanced computing and biotechnology, showcasing how AI-driven approaches are opening doors to new therapeutic possibilities. We'll discuss the challenges, breakthroughs, and ethical considerations of using AI to navigate the complex landscape of 'undruggable' targets, highlighting the potential for significant medical advancements. #SynBioBeta2024
